| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SH2 domain binding | 8.38e-05 | 52 | 172 | 5 | GO:0042169 | |
| GeneOntologyMolecularFunction | IgM binding | 9.85e-05 | 11 | 172 | 3 | GO:0001791 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | SMAP1 PLEKHG4 ARFGEF1 ALS2 BCR DENND2B MADD ARFGEF3 ARHGAP12 AGFG1 FGD5 IQGAP3 TNS3 PLCE1 | 1.31e-04 | 507 | 172 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | SMAP1 PLEKHG4 ARFGEF1 ALS2 BCR DENND2B MADD ARFGEF3 ARHGAP12 AGFG1 FGD5 IQGAP3 TNS3 PLCE1 | 1.31e-04 | 507 | 172 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.82e-04 | 231 | 172 | 9 | GO:0005085 | |
| GeneOntologyMolecularFunction | chromatin binding | ZNF609 INSM1 ASH1L RNF8 NSD1 ORC1 NCOR2 POLR3D KAT8 H1-4 H1-5 KMT2A MLLT3 ELK4 HSF1 TTC5 CREB3 | 2.27e-04 | 739 | 172 | 17 | GO:0003682 |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 3.96e-05 | 112 | 172 | 7 | GO:0032588 | |
| GeneOntologyCellularComponent | M band | 1.17e-04 | 31 | 172 | 4 | GO:0031430 | |
| GeneOntologyCellularComponent | podosome | 3.53e-04 | 41 | 172 | 4 | GO:0002102 | |
| HumanPheno | Bowing of the long bones | RPGRIP1 COL12A1 SPTBN1 NSD1 BCR ARCN1 TFE3 BGN ORC1 SH3PXD2B IARS2 ANAPC1 VPS13B | 2.62e-05 | 316 | 56 | 13 | HP:0006487 |
| HumanPheno | Anomaly of the limb diaphyses | RPGRIP1 COL12A1 SPTBN1 NSD1 BCR ARCN1 TFE3 BGN ORC1 SH3PXD2B IARS2 ANAPC1 VPS13B | 3.20e-05 | 322 | 56 | 13 | HP:0006504 |
| Domain | Ig-like_fold | LILRA2 COL12A1 PSG5 NXPE4 LILRB2 MPZL1 NXPE1 NECTIN3 DCC CMYA5 LRIT3 IGSF10 SHANK2 IL1RAPL2 ALPK3 LINGO4 ROS1 FCMR | 6.90e-05 | 706 | 168 | 18 | IPR013783 |
| Domain | SLRP_I_decor/aspor/byglycan | 2.40e-04 | 3 | 168 | 2 | IPR016352 | |
| Domain | PDZ | 2.89e-04 | 141 | 168 | 7 | PF00595 | |
| Domain | CH | 2.96e-04 | 65 | 168 | 5 | SM00033 | |
| Domain | - | LILRA2 COL12A1 PSG5 NXPE4 MPZL1 NXPE1 NECTIN3 DCC CMYA5 LRIT3 IGSF10 IL1RAPL2 ALPK3 LINGO4 ROS1 FCMR | 3.28e-04 | 663 | 168 | 16 | 2.60.40.10 |
| Domain | Post-SET_dom | 3.67e-04 | 16 | 168 | 3 | IPR003616 | |
| Domain | PostSET | 3.67e-04 | 16 | 168 | 3 | SM00508 | |
| Domain | POST_SET | 3.67e-04 | 16 | 168 | 3 | PS50868 | |
| Domain | PDZ | 3.88e-04 | 148 | 168 | 7 | SM00228 | |
| Domain | CH | 4.19e-04 | 70 | 168 | 5 | PF00307 | |
| Domain | - | 4.21e-04 | 150 | 168 | 7 | 2.30.42.10 | |
| Domain | PDZ | 4.38e-04 | 151 | 168 | 7 | PS50106 | |
| Domain | IG | LILRA2 PSG5 LILRB2 MPZL1 NECTIN3 DCC LRIT3 IGSF10 IL1RAPL2 ALPK3 LINGO4 FCMR | 4.39e-04 | 421 | 168 | 12 | SM00409 |
| Domain | Ig_sub | LILRA2 PSG5 LILRB2 MPZL1 NECTIN3 DCC LRIT3 IGSF10 IL1RAPL2 ALPK3 LINGO4 FCMR | 4.39e-04 | 421 | 168 | 12 | IPR003599 |
| Domain | - | 4.47e-04 | 71 | 168 | 5 | 1.10.418.10 | |
| Domain | PDZ | 4.56e-04 | 152 | 168 | 7 | IPR001478 | |
| Domain | DCB_dom | 4.77e-04 | 4 | 168 | 2 | IPR032629 | |
| Domain | Sec7_C | 4.77e-04 | 4 | 168 | 2 | IPR015403 | |
| Domain | DUF1981 | 4.77e-04 | 4 | 168 | 2 | PF09324 | |
| Domain | DCB | 4.77e-04 | 4 | 168 | 2 | PF16213 | |
| Domain | CH | 5.09e-04 | 73 | 168 | 5 | PS50021 | |
| Domain | CH-domain | 5.76e-04 | 75 | 168 | 5 | IPR001715 | |
| Domain | AWS | 7.90e-04 | 5 | 168 | 2 | SM00570 | |
| Domain | AWS | 7.90e-04 | 5 | 168 | 2 | PS51215 | |
| Domain | AWS_dom | 7.90e-04 | 5 | 168 | 2 | IPR006560 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L AFTPH SPTBN1 PARD3B ALS2 BCR SPECC1 DENND2B MADD PIK3R4 GRIP1 STIM1 ARFGEF3 SH3PXD2B MDN1 MAST4 TJP1 AGFG1 NAV2 KMT2A EIF4G3 CEP170B TNS3 KIF11 AHNAK2 | 1.65e-12 | 861 | 174 | 25 | 36931259 |
| Pubmed | ATXN2L ZNF536 ZNF609 ATP7B NACA MPZL1 SPG11 NUP214 NECTIN3 BCR MADD IARS2 ANAPC1 TJP1 MACO1 AGFG1 CDK11B CLSPN MGA TNS3 | 9.53e-10 | 733 | 174 | 20 | 34672954 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATXN2L AFTPH ANK2 COPB1 NACA GEMIN5 NUP214 GPRIN1 ARCN1 PPP1R10 IARS2 MRTFB GSE1 TJP1 H1-4 AGFG1 KMT2A ACIN1 LTV1 EIF4G3 KIF11 AHNAK2 | 1.99e-09 | 934 | 174 | 22 | 33916271 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | FOXM1 BDP1 ATXN2L RNF8 BCR RUFY3 ARFGEF3 NCOR2 MRTFB GSE1 ANAPC1 MACO1 AGFG1 CDK11B CLSPN KAT14 CEP170B | 7.96e-09 | 588 | 174 | 17 | 38580884 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CRYBG2 NSD1 GEMIN5 NUP214 BCR TFE3 MADD JAK2 ORC1 NCOR2 SH3PXD2B FAT1 MDN1 SHANK2 CASKIN1 NAV2 TTC5 IQGAP3 CEP170B PICK1 CREB3 GAREM1 AHNAK2 | 8.48e-09 | 1105 | 174 | 23 | 35748872 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | AFTPH PARD3B AZI2 LCP1 BCR CEP164 ARCN1 GRIP1 SH3PXD2B IARS2 MRTFB CEP120 MAST4 TJP1 CAPN7 MACO1 ARHGAP12 LTV1 MGA CEP170B | 1.23e-08 | 853 | 174 | 20 | 28718761 |
| Pubmed | ATXN2L SMAP1 ANK2 RPN1 MARK1 SPTBN1 NACA GPRIN1 BCR ARCN1 RUFY3 MADD STIM1 ARFGEF3 SLC6A11 SHANK2 TJP1 CASKIN1 H1-4 H1-5 EIF4G3 CEP170B CYB5A | 1.48e-08 | 1139 | 174 | 23 | 36417873 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 SPTBN1 SPG11 NUP214 LCP1 GPRIN1 RYR3 PIK3R4 PPP1R10 MDN1 CAPN7 NAV2 KMT2A RBM46 CDK11B | 3.59e-08 | 497 | 174 | 15 | 36774506 |
| Pubmed | SMAP1 COPB1 CFAP36 MPZL1 ARFGEF1 MUC16 GPRIN1 ARCN1 RUFY3 STIM1 ARFGEF3 IARS2 FAT1 TJP1 H1-4 CLSPN EIF4G3 MGA | 8.24e-08 | 777 | 174 | 18 | 35844135 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | PDPR ATP7B IMPA2 PLEKHG4 DTNB NACA MPZL1 SLC35A1 RNF8 ARFGEF1 SPG11 NECTIN3 JAK2 IARS2 FAT1 MDN1 MACO1 ABCB8 CEP170B CYB5A GNPAT | 9.26e-08 | 1061 | 174 | 21 | 33845483 |
| Pubmed | ZNF536 ZNF609 GEMIN5 NUP214 BCR TXNIP NCOR2 MRTFB GSE1 ANAPC1 MGA KAT14 KIF11 | 2.15e-07 | 418 | 174 | 13 | 34709266 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SMAP1 AFTPH COPB1 BCR ARCN1 TFE3 MADD PIK3R4 POLR3D MRTFB SHANK2 TJP1 ARHGAP12 AGFG1 MLLT3 LTV1 CLSPN TNS3 GAREM1 GNPAT | 2.93e-07 | 1038 | 174 | 20 | 26673895 |
| Pubmed | ATXN2L RPN1 NSD1 GEMIN5 GPRIN1 ARCN1 PPP1R10 SH3PXD2B MRTFB ANAPC1 TJP1 KMT2A ACIN1 MGA | 7.88e-07 | 549 | 174 | 14 | 38280479 | |
| Pubmed | RPGRIP1 ANK2 RPN1 DTNB SPTBN1 ASH1L SPG11 DCC LCP1 MDN1 SHANK2 TJP1 ARHGAP12 H1-4 H1-5 NAV2 KMT2A ACIN1 EIF4G3 PCDHGA8 PICK1 KIF11 FCMR | 9.68e-07 | 1442 | 174 | 23 | 35575683 | |
| Pubmed | ZNF536 ALS2 NUP214 MADD ARFGEF3 SEMA6D GSE1 MEGF9 ACIN1 CEP170B VPS13B PLCE1 | 1.12e-06 | 407 | 174 | 12 | 12693553 | |
| Pubmed | ATXN2L COPB1 SPTBN1 NSD1 GEMIN5 NUP214 LCP1 IARS2 MDN1 ANAPC1 TJP1 H1-4 KMT2A ACIN1 EIF4G3 | 1.16e-06 | 653 | 174 | 15 | 22586326 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | A2M ATXN2L SMAP1 PDPR COPB1 CFAP36 SPTBN1 NACA ARFGEF1 GEMIN5 NUP214 GPRIN1 ARCN1 NCOR2 SH3PXD2B IARS2 MRTFB TJP1 ACIN1 TNS3 KIF11 AHNAK2 | 1.47e-06 | 1367 | 174 | 22 | 32687490 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FOXM1 ATXN2L AFTPH SPTBN1 GEMIN5 NUP214 GPRIN1 TERF2IP NCOR2 MDN1 GSE1 ANAPC1 KMT2A ACIN1 CDK11B HSF1 | 1.97e-06 | 774 | 174 | 16 | 15302935 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.03e-06 | 123 | 174 | 7 | 26912792 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2L ZNF609 GEMIN5 BCR STIM1 PPP1R10 SH3PXD2B ANAPC1 TJP1 H1-5 AGFG1 EIF4G3 MGA TNS3 AHNAK2 | 4.07e-06 | 724 | 174 | 15 | 36232890 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ATXN2L SPTBN1 MPZL1 NUP214 GPRIN1 SPECC1 STIM1 SH3PXD2B MRTFB SHANK2 TJP1 AGFG1 NAV2 | 6.02e-06 | 565 | 174 | 13 | 25468996 |
| Pubmed | A2M PSG5 SPTBN1 ASH1L DENND2B GRIP1 TXNIP PPP1R10 NCOR2 MRTFB MAST4 MACO1 MGA | 9.72e-06 | 591 | 174 | 13 | 15231748 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.08e-05 | 208 | 174 | 8 | 33230847 | |
| Pubmed | ATXN2L ANK2 SPTBN1 GPRIN1 SPECC1 MADD SHANK2 CASKIN1 EIF4G3 CEP170B | 1.09e-05 | 347 | 174 | 10 | 17114649 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ZNF609 AFTPH NUP214 NCOR2 MRTFB CCDC87 AGFG1 CLSPN EIF4G3 MGA GAREM1 | 1.20e-05 | 430 | 174 | 11 | 35044719 |
| Pubmed | ZNF536 ZNF609 ATP7B CFAP36 ASH1L BCR NCOR2 FAT1 GSE1 CCNB3 ANAPC1 H1-4 H1-5 CLSPN MGA VPS53 KAT14 CEP170B | 1.37e-05 | 1116 | 174 | 18 | 31753913 | |
| Pubmed | ATXN2L ANK2 COPB1 RPN1 SPTBN1 NUP214 GPRIN1 ARCN1 GRIP1 STIM1 ARHGAP12 H1-4 LTV1 EIF4G3 | 1.45e-05 | 708 | 174 | 14 | 39231216 | |
| Pubmed | 1.45e-05 | 104 | 174 | 6 | 9205841 | ||
| Pubmed | ATXN2L COPB1 SPTBN1 NACA ARCN1 MADD PPP1R10 NCOR2 MDN1 AGFG1 CDK11B AHNAK2 | 1.88e-05 | 538 | 174 | 12 | 28524877 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | COPB1 NUP214 LCP1 SPECC1 ARCN1 ORC1 ACIN1 CDK11B EIF4G3 KIF11 | 1.89e-05 | 370 | 174 | 10 | 22922362 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.31e-05 | 231 | 174 | 8 | 16452087 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 27336410 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 20395514 | ||
| Pubmed | Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias. | 2.49e-05 | 2 | 174 | 2 | 32768438 | |
| Pubmed | Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas. | 2.49e-05 | 2 | 174 | 2 | 36206767 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 33982216 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 38576284 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 21959947 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 24831003 | ||
| Pubmed | The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization. | 2.49e-05 | 2 | 174 | 2 | 9441747 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 16442619 | ||
| Pubmed | BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism. | 2.49e-05 | 2 | 174 | 2 | 18216868 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 31209033 | ||
| Pubmed | A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia. | 2.49e-05 | 2 | 174 | 2 | 18503828 | |
| Pubmed | Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F. | 2.49e-05 | 2 | 174 | 2 | 18033315 | |
| Pubmed | Human spleen histone H1. Isolation and amino acid sequence of a main variant, H1b. | 2.49e-05 | 2 | 174 | 2 | 3782055 | |
| Pubmed | Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytes. | 2.49e-05 | 2 | 174 | 2 | 15262991 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 23192351 | ||
| Pubmed | Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors. | 2.49e-05 | 2 | 174 | 2 | 37587872 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 14766217 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 27344946 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 25691062 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 21785467 | ||
| Pubmed | The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA. | 2.49e-05 | 2 | 174 | 2 | 12023981 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 22384256 | ||
| Pubmed | MLL-AF9 regulates transcriptional initiation in mixed lineage leukemic cells. | 2.49e-05 | 2 | 174 | 2 | 39002676 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 33637563 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 23178754 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 35147301 | ||
| Pubmed | Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development. | 2.49e-05 | 2 | 174 | 2 | 11265751 | |
| Pubmed | Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia. | 2.49e-05 | 2 | 174 | 2 | 25632041 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 38796094 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 22427200 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 30387535 | ||
| Pubmed | A2M ZNF609 NACA BCR MADD PIK3R4 GSE1 H1-4 KMT2A CLSPN IQGAP3 GNPAT PLCE1 | 2.63e-05 | 650 | 174 | 13 | 38777146 | |
| Pubmed | CRYBG2 PARD3B NUP214 TERF2IP PPP1R10 HASPIN KMT2A ACIN1 CDK11B TTC5 UNC79 | 2.67e-05 | 469 | 174 | 11 | 27634302 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF609 RPN1 NSD1 NUP214 TERF2IP TFE3 ORC1 PPP1R10 NCOR2 MDN1 ANAPC1 MACO1 KAT8 H1-4 H1-5 KMT2A ACIN1 MGA KAT14 | 2.86e-05 | 1294 | 174 | 19 | 30804502 |
| Pubmed | 3.08e-05 | 313 | 174 | 9 | 20800603 | ||
| Pubmed | 3.37e-05 | 396 | 174 | 10 | 26687479 | ||
| Pubmed | ATXN2L SMAP1 ANK2 COPB1 RPN1 MARK1 SPTBN1 GEMIN5 BCR SPECC1 ARCN1 RUFY3 MADD PIK3R4 SHANK2 TJP1 CASKIN1 KMT2A EIF4G3 CEP170B | 3.49e-05 | 1431 | 174 | 20 | 37142655 | |
| Pubmed | 4.30e-05 | 14 | 174 | 3 | 16452088 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.78e-05 | 256 | 174 | 8 | 33397691 | |
| Pubmed | AFTPH COPB1 RPN1 SPTBN1 STIM1 TJP1 ABCB8 H1-4 H1-5 CEP170B CREB3 | 5.03e-05 | 503 | 174 | 11 | 36217030 | |
| Pubmed | ATP7B ARFGEF1 SPG11 GPRIN1 RUFY3 MADD PIK3R4 STIM1 ARFGEF3 MACO1 VPS13B | 5.12e-05 | 504 | 174 | 11 | 34432599 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | COPB1 PLEKHG4 RPN1 SPTBN1 NACA GEMIN5 NUP214 ARCN1 PIK3R4 ORC1 NCOR2 MDN1 H1-5 ACIN1 LTV1 MGA TNS3 KIF11 AHNAK2 | 5.20e-05 | 1353 | 174 | 19 | 29467282 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MARK1 DTNB AZI2 BCR SPECC1 PIK3R4 STIM1 JAK2 NCOR2 ANAPC1 CAPN7 KMT2A CDK11B CLSPN TNS3 | 5.80e-05 | 910 | 174 | 15 | 36736316 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | COPB1 RPN1 SPTBN1 ASH1L ARCN1 IARS2 MDN1 H1-4 H1-5 KMT2A RBM46 UNC79 IQGAP3 AHNAK2 | 6.01e-05 | 807 | 174 | 14 | 30575818 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 ZNF609 IMPA2 DTNB ASH1L PARD3B BCR DENND2B TERF2IP ARFGEF3 JAK2 NCOR2 MRTFB SHANK2 TJP1 ELK4 EIF4G3 CEP170B VPS13B CYB5A | 6.05e-05 | 1489 | 174 | 20 | 28611215 |
| Pubmed | 6.42e-05 | 197 | 174 | 7 | 36604605 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 25238203 | ||
| Pubmed | Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice. | 7.44e-05 | 3 | 174 | 2 | 19932218 | |
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 22847163 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 27526106 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 23062104 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 32549410 | ||
| Pubmed | FLT3N676K drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis. | 7.44e-05 | 3 | 174 | 2 | 30953031 | |
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 29992755 | ||
| Pubmed | Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. | 7.44e-05 | 3 | 174 | 2 | 18538732 | |
| Pubmed | Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia. | 7.44e-05 | 3 | 174 | 2 | 21183952 | |
| Pubmed | Asporin-deficient mice have tougher skin and altered skin glycosaminoglycan content and structure. | 7.44e-05 | 3 | 174 | 2 | 28859141 | |
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 8943370 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 21937695 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 12370803 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 11152695 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 36358022 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 18784740 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 22915106 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 16328057 | ||
| Pubmed | 7.44e-05 | 3 | 174 | 2 | 23624644 | ||
| Pubmed | Dendritic spine morphology and memory formation depend on postsynaptic Caskin proteins. | 7.44e-05 | 3 | 174 | 2 | 31727973 | |
| Interaction | MAPRE3 interactions | NCKAP5 BCR SPECC1 PIK3R4 STIM1 SH3PXD2B IARS2 MAST4 MACO1 NAV2 CEP170B PICK1 KIF11 | 6.59e-08 | 230 | 167 | 13 | int:MAPRE3 |
| Interaction | YWHAH interactions | ATXN2L AFTPH MARK1 SPTBN1 PARD3B ALS2 BCR SPECC1 DENND2B TFE3 MADD PIK3R4 GRIP1 STIM1 ARFGEF3 SH3PXD2B IARS2 MAST4 TJP1 AGFG1 NAV2 KMT2A EIF4G3 CEP170B TNS3 KIF11 AHNAK2 | 3.93e-07 | 1102 | 167 | 27 | int:YWHAH |
| Interaction | YWHAG interactions | ATXN2L AFTPH COPB1 MARK1 SPTBN1 PARD3B ALS2 BCR SPECC1 DENND2B TFE3 PIK3R4 GRIP1 STIM1 JAK2 IARS2 MDN1 MAST4 TJP1 AGFG1 NAV2 KMT2A ACIN1 CDK11B EIF4G3 CEP170B TNS3 GAREM1 AHNAK2 | 4.12e-07 | 1248 | 167 | 29 | int:YWHAG |
| Interaction | H3C1 interactions | ANK2 NACA ASH1L NSD1 GPRIN1 TFE3 GRIP1 CCNB3 ANAPC1 KAT8 HASPIN H1-4 H1-5 NAV2 KMT2A MLLT3 LTV1 ELK4 HSF1 MGA KAT14 KIF11 | 5.57e-06 | 901 | 167 | 22 | int:H3C1 |
| Interaction | YWHAQ interactions | ATXN2L AFTPH MARK1 RNF8 PARD3B ALS2 BCR SPECC1 DENND2B TFE3 GRIP1 IARS2 MAST4 TJP1 MACO1 AGFG1 NAV2 KMT2A FGD5 CDK11B HSF1 UNC79 CEP170B TNS3 GAREM1 | 5.66e-06 | 1118 | 167 | 25 | int:YWHAQ |
| Interaction | OTUD7A interactions | 8.39e-06 | 58 | 167 | 6 | int:OTUD7A | |
| Interaction | FBXO22 interactions | BDP1 SPTBN1 SPG11 NUP214 LCP1 GPRIN1 RYR3 PIK3R4 PPP1R10 NCOR2 MDN1 CAPN7 NAV2 KMT2A RBM46 CDK11B | 1.14e-05 | 540 | 167 | 16 | int:FBXO22 |
| Interaction | YWHAE interactions | ATXN2L MARK1 RNF8 PARD3B ALS2 BCR SPECC1 DENND2B TFE3 PIK3R4 GRIP1 STIM1 JAK2 NCOR2 IARS2 MAST4 CAPN7 KAT8 NAV2 KMT2A FGD5 CDK11B HSF1 MGA CEP170B GAREM1 | 1.41e-05 | 1256 | 167 | 26 | int:YWHAE |
| Interaction | RGMA interactions | 1.60e-05 | 19 | 167 | 4 | int:RGMA | |
| Interaction | NUP43 interactions | ZNF609 ASH1L NSD1 ATP13A5 NUP214 STIM1 NCOR2 MRTFB GSE1 KAT8 H1-4 KMT2A ACIN1 CDK11B EIF4G3 MGA AHNAK2 | 1.81e-05 | 625 | 167 | 17 | int:NUP43 |
| Interaction | SFN interactions | ATXN2L AFTPH MARK1 SPTBN1 RNF8 PARD3B BCR SPECC1 DENND2B TFE3 GRIP1 MAST4 TJP1 NAV2 KMT2A CEP170B TNS3 AHNAK2 | 1.84e-05 | 692 | 167 | 18 | int:SFN |
| Interaction | NAA40 interactions | ATXN2L AFTPH ANK2 COPB1 NACA GEMIN5 NUP214 GPRIN1 ARCN1 PPP1R10 IARS2 MRTFB GSE1 TJP1 H1-4 AGFG1 KMT2A ACIN1 LTV1 EIF4G3 KIF11 AHNAK2 | 2.00e-05 | 978 | 167 | 22 | int:NAA40 |
| Interaction | GJA1 interactions | A2M RPN1 MARK1 SPTBN1 ARFGEF1 GPRIN1 SPECC1 ARCN1 PIK3R4 STIM1 IARS2 TJP1 MACO1 VPS13B CREB3 KIF11 | 2.89e-05 | 583 | 167 | 16 | int:GJA1 |
| Interaction | YWHAZ interactions | BDP1 ATXN2L COPB1 MARK1 SPTBN1 RNF8 PARD3B ALS2 BCR SPECC1 DENND2B TFE3 MADD GRIP1 STIM1 MAST4 TJP1 MACO1 KAT8 NAV2 KMT2A CDK11B HSF1 CEP170B KIF11 GAREM1 | 3.27e-05 | 1319 | 167 | 26 | int:YWHAZ |
| Interaction | KCNA3 interactions | ATXN2L ANK2 COPB1 RPN1 SPTBN1 NACA NUP214 GPRIN1 SPECC1 ARCN1 GRIP1 STIM1 ORC1 ARHGAP12 H1-4 KMT2A LTV1 EIF4G3 IQGAP3 KIF11 | 3.68e-05 | 871 | 167 | 20 | int:KCNA3 |
| Interaction | CBX8 interactions | 4.49e-05 | 249 | 167 | 10 | int:CBX8 | |
| Interaction | ASF1A interactions | 4.49e-05 | 249 | 167 | 10 | int:ASF1A | |
| Interaction | HSPB2 interactions | 4.52e-05 | 200 | 167 | 9 | int:HSPB2 | |
| Interaction | RHOF interactions | RPN1 MARK1 SPTBN1 MPZL1 NECTIN3 GPRIN1 SPECC1 STIM1 FAT1 MDN1 SEMA6D TJP1 ARHGAP12 AGFG1 IQGAP3 VPS13B TNS3 | 4.58e-05 | 673 | 167 | 17 | int:RHOF |
| Interaction | BICD1 interactions | AZI2 LCP1 CEP164 SH3PXD2B CEP120 TJP1 MACO1 ARHGAP12 H1-5 CEP170B | 4.64e-05 | 250 | 167 | 10 | int:BICD1 |
| Interaction | SHANK3 interactions | ANK2 SPTBN1 NACA GPRIN1 BCR ARFGEF3 SH3PXD2B SHANK2 CASKIN1 ARHGAP12 H1-5 EIF4G3 LRRC73 PICK1 | 6.90e-05 | 496 | 167 | 14 | int:SHANK3 |
| Interaction | CPZ interactions | 7.97e-05 | 28 | 167 | 4 | int:CPZ | |
| Interaction | KANSL3 interactions | 8.05e-05 | 86 | 167 | 6 | int:KANSL3 | |
| Interaction | CRYBG2 interactions | 9.19e-05 | 29 | 167 | 4 | int:CRYBG2 | |
| Interaction | STX6 interactions | MTIF3 SMAP1 AFTPH SPTBN1 MARCHF2 ARFGEF1 GPRIN1 STIM1 MACO1 AGFG1 VPS53 VPS13B AHNAK2 | 9.58e-05 | 448 | 167 | 13 | int:STX6 |
| Interaction | LAMTOR1 interactions | ATP7B MARK1 SPTBN1 MPZL1 ARFGEF1 SPG11 GPRIN1 SPECC1 RUFY3 TFE3 PIK3R4 ARFGEF3 IARS2 AGFG1 VPS53 VPS13B CYB5A | 1.08e-04 | 722 | 167 | 17 | int:LAMTOR1 |
| Interaction | KLF3 interactions | 1.24e-04 | 228 | 167 | 9 | int:KLF3 | |
| Interaction | CCNT2 interactions | 1.63e-04 | 62 | 167 | 5 | int:CCNT2 | |
| Interaction | NANOG interactions | FOXM1 ATXN2L ZNF609 PDPR MUC16 SPECC1 TFE3 ORC1 NCOR2 MDN1 KAT8 HASPIN MGA | 1.93e-04 | 481 | 167 | 13 | int:NANOG |
| GeneFamily | PDZ domain containing | 6.95e-05 | 152 | 120 | 7 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.19e-04 | 161 | 120 | 6 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.68e-04 | 66 | 120 | 4 | 722 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.47e-03 | 34 | 120 | 3 | 487 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.53e-03 | 9 | 120 | 2 | 1234 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.53e-03 | 206 | 120 | 6 | 682 | |
| GeneFamily | Small leucine rich repeat proteoglycans | 2.76e-03 | 12 | 120 | 2 | 573 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | A2M RPGRIP1 COL12A1 CABP7 INSL4 INSM1 ALS2 NECTIN3 GRIP1 NAV2 RBM46 FKBP14 | 1.09e-06 | 309 | 173 | 12 | MM1244 |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | A2M RPGRIP1 COL12A1 CABP7 INSM1 ALS2 NECTIN3 GRIP1 NAV2 RBM46 FKBP14 | 1.30e-06 | 259 | 173 | 11 | M9331 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 ZNF354A ANK2 MARK1 ARFGEF1 DCC TERF2IP RUFY3 GRIP1 ARFGEF3 MDN1 MAST4 SHANK2 SEMA6D GSE1 MEGF9 MACO1 CASKIN1 MLLT3 UNC79 VPS53 AHNAK2 | 4.09e-06 | 1106 | 173 | 22 | M39071 |
| Coexpression | GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN | 7.41e-06 | 199 | 173 | 9 | M6275 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.07e-05 | 323 | 173 | 11 | M9150 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | CABP7 MARK1 CFAP36 INSM1 ASH1L AZI2 NECTIN3 TERF2IP RUFY3 MADD NCOR2 MAST4 SEMA6D GSE1 MEGF9 CAPN7 NAV2 EIF4G3 UNC79 | 1.70e-05 | 946 | 173 | 19 | M39169 |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP | 5.76e-05 | 200 | 173 | 8 | M6371 | |
| Coexpression | GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP | 5.76e-05 | 200 | 173 | 8 | M6950 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | NCKAP5 ZMAT4 GRIP1 ARFGEF3 FAT1 MAST4 SHANK2 SEMA6D NAV2 MLLT3 CYB5A GAREM1 | 6.74e-12 | 180 | 173 | 12 | b509c7d6bdfba672065fb722874bdc68de72ba1c |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | NCKAP5 ZMAT4 GRIP1 ARFGEF3 FAT1 MAST4 SHANK2 MLLT3 CYB5A GAREM1 | 3.42e-09 | 187 | 173 | 10 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | NCKAP5 ZMAT4 GRIP1 ARFGEF3 FAT1 MAST4 SHANK2 MLLT3 CYB5A GAREM1 | 4.19e-09 | 191 | 173 | 10 | 23776c7302cead3881b39127398f3b3e0d27885e |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | NCKAP5 GRIP1 ARFGEF3 FAT1 MAST4 SHANK2 NAV2 MLLT3 CYB5A GAREM1 | 4.63e-09 | 193 | 173 | 10 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | NCKAP5 ZMAT4 GRIP1 ARFGEF3 FAT1 MAST4 SHANK2 MLLT3 CYB5A PLCE1 | 5.11e-09 | 195 | 173 | 10 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.17e-08 | 182 | 173 | 9 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-08 | 184 | 173 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-08 | 184 | 173 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-08 | 184 | 173 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.02e-08 | 186 | 173 | 9 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.76e-08 | 189 | 173 | 9 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.03e-08 | 190 | 173 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 6.59e-08 | 192 | 173 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 6.89e-08 | 193 | 173 | 9 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 7.53e-08 | 195 | 173 | 9 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 7.53e-08 | 195 | 173 | 9 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-08 | 195 | 173 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COPD-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 7.87e-08 | 196 | 173 | 9 | af96fb94886e9395f3e2cd0a293af29229d017fe | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.58e-08 | 198 | 173 | 9 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-07 | 149 | 173 | 8 | 4b44108c40376a6b73258df40d2424e68f991383 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-07 | 171 | 173 | 8 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-07 | 171 | 173 | 8 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.76e-07 | 177 | 173 | 8 | 174c54acfe19e2bb31418d69e228032ba724cbb6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.97e-07 | 178 | 173 | 8 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.97e-07 | 178 | 173 | 8 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-07 | 179 | 173 | 8 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 5.64e-07 | 181 | 173 | 8 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-07 | 182 | 173 | 8 | ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.39e-07 | 184 | 173 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.39e-07 | 184 | 173 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.65e-07 | 185 | 173 | 8 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.65e-07 | 185 | 173 | 8 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 6.93e-07 | 186 | 173 | 8 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 7.21e-07 | 187 | 173 | 8 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.82e-07 | 189 | 173 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 8.13e-07 | 190 | 173 | 8 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.80e-07 | 192 | 173 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 8.80e-07 | 192 | 173 | 8 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | distal-2-Hematologic-Myeloid_Dendritic_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.52e-07 | 194 | 173 | 8 | 6881cfe12837a32e598535a564e4c31d4846167b | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 9.89e-07 | 195 | 173 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 9.89e-07 | 195 | 173 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-07 | 195 | 173 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 196 | 173 | 8 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.03e-06 | 196 | 173 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.03e-06 | 196 | 173 | 8 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.07e-06 | 197 | 173 | 8 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.11e-06 | 198 | 173 | 8 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-06 | 198 | 173 | 8 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-06 | 198 | 173 | 8 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.11e-06 | 198 | 173 | 8 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.11e-06 | 198 | 173 | 8 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Sigmoid / Region, Cell class and subclass | 1.15e-06 | 199 | 173 | 8 | bd6f8c0f79e9a94cc0f8c6105d38851463de821c | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(52)_cycling_DCs|Sigmoid / shred on region, Cell_type, and subtype | 1.15e-06 | 199 | 173 | 8 | 8ee78a39729633bcbb3ab17e1dfaca33f38db569 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-06 | 199 | 173 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.40e-06 | 162 | 173 | 7 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | 3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 3.54e-06 | 163 | 173 | 7 | 47300dec94dc66e965bf71fafff0a9fd24fae968 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-06 | 165 | 173 | 7 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-06 | 165 | 173 | 7 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-06 | 165 | 173 | 7 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 4.49e-06 | 169 | 173 | 7 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-06 | 169 | 173 | 7 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 4.67e-06 | 170 | 173 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 4.67e-06 | 170 | 173 | 7 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.67e-06 | 170 | 173 | 7 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-06 | 171 | 173 | 7 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-06 | 171 | 173 | 7 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-06 | 171 | 173 | 7 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 172 | 173 | 7 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 5.44e-06 | 174 | 173 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.65e-06 | 175 | 173 | 7 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-06 | 176 | 173 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.86e-06 | 176 | 173 | 7 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 178 | 173 | 7 | d3cbdec9d75f076e565baca05ede292cca7758a4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.32e-06 | 178 | 173 | 7 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.55e-06 | 179 | 173 | 7 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.55e-06 | 179 | 173 | 7 | e1bfd553c043ebc070ccf8545d489ba16d9b2ef4 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 180 | 173 | 7 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 180 | 173 | 7 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | IIH-cycling-|IIH / Condition, Cell_class and T cell subcluster | 7.05e-06 | 181 | 173 | 7 | 7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078 | |
| ToppCell | IIH-cycling|IIH / Condition, Cell_class and T cell subcluster | 7.05e-06 | 181 | 173 | 7 | ec3e782ce93dcfe1a54fb7284e4e39063614b0e2 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 7.57e-06 | 183 | 173 | 7 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 7.57e-06 | 183 | 173 | 7 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.57e-06 | 183 | 173 | 7 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 7.84e-06 | 184 | 173 | 7 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.84e-06 | 184 | 173 | 7 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 7.84e-06 | 184 | 173 | 7 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-06 | 184 | 173 | 7 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-06 | 184 | 173 | 7 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 7.84e-06 | 184 | 173 | 7 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 8.13e-06 | 185 | 173 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.13e-06 | 185 | 173 | 7 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 8.13e-06 | 185 | 173 | 7 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.13e-06 | 185 | 173 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 8.13e-06 | 185 | 173 | 7 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.13e-06 | 185 | 173 | 7 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.42e-06 | 186 | 173 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 8.72e-06 | 187 | 173 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.72e-06 | 187 | 173 | 7 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.72e-06 | 187 | 173 | 7 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.16e-05 | 50 | 111 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | ZNF609 NECTIN3 RUFY3 TXNIP JAK2 MRTFB MAST4 SHANK2 MLLT3 VPS13B | 1.30e-06 | 183 | 171 | 10 | 5613_DN |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; HL60; HT_HG-U133A | 2.41e-06 | 196 | 171 | 10 | 2969_UP | |
| Disease | cortical thickness | A2M ZNF536 COL12A1 SPTBN1 NCKAP5 SPECC1 KLHL38 GRIP1 SH3PXD2B CEP120 MAST4 MEGF9 ARHGAP12 NAV2 KMT2A EIF4G3 PICK1 PLCE1 | 7.52e-05 | 1113 | 169 | 18 | EFO_0004840 |
| Disease | Juvenile amyotrophic lateral sclerosis | 9.75e-05 | 3 | 169 | 2 | cv:C3468114 | |
| Disease | Juvenile amyotrophic lateral sclerosis | 1.94e-04 | 4 | 169 | 2 | C3468114 | |
| Disease | Weaver syndrome | 3.22e-04 | 5 | 169 | 2 | C0265210 | |
| Disease | ficolin-2 measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0008135 | |
| Disease | SUN domain-containing protein 3 measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0802102 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 4.20e-04 | 61 | 169 | 4 | C1961102 | |
| Disease | peripheral neuropathy, response to bortezomib | 4.82e-04 | 6 | 169 | 2 | EFO_0003100, EFO_0007808 | |
| Disease | myelofibrosis (implicated_via_orthology) | 4.82e-04 | 6 | 169 | 2 | DOID:4971 (implicated_via_orthology) | |
| Disease | fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement | 6.72e-04 | 7 | 169 | 2 | EFO_0004612, EFO_0600007 | |
| Disease | lifestyle measurement, diastolic blood pressure | 6.72e-04 | 7 | 169 | 2 | EFO_0006336, EFO_0010724 | |
| Disease | cortical surface area measurement | ATXN2L ZNF536 COPB1 SPTBN1 PARD3B NCKAP5 NECTIN3 BCR TMEM273 GRIP1 CEP120 MAST4 TJP1 ARHGAP12 AGFG1 NAV2 MLLT3 PLCE1 | 7.40e-04 | 1345 | 169 | 18 | EFO_0010736 |
| Disease | Colorectal Carcinoma | PCSK2 ATP7B ANK2 CD109 ARFGEF1 DCC FAT1 GSE1 CCNB3 H1-4 H1-5 ACIN1 | 7.65e-04 | 702 | 169 | 12 | C0009402 |
| Disease | waist circumference | 8.63e-04 | 429 | 169 | 9 | EFO_0004342 | |
| Disease | LEUKEMIA, ACUTE LYMPHOBLASTIC | 8.93e-04 | 8 | 169 | 2 | 613065 | |
| Disease | myelofibrosis (is_implicated_in) | 8.93e-04 | 8 | 169 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | Acute lymphoid leukemia | 8.93e-04 | 8 | 169 | 2 | cv:C0023449 | |
| Disease | underweight body mass index status | 1.14e-03 | 9 | 169 | 2 | EFO_0005936 | |
| Disease | chronic central serous retinopathy | 1.14e-03 | 9 | 169 | 2 | EFO_0009363 | |
| Disease | ascending aortic diameter | 1.30e-03 | 140 | 169 | 5 | EFO_0021787 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.40e-03 | 84 | 169 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | clonal hematopoiesis | 1.42e-03 | 10 | 169 | 2 | EFO_0010819 | |
| Disease | lean body mass | 1.60e-03 | 379 | 169 | 8 | EFO_0004995 | |
| Disease | interleukin-6 measurement, response to stimulus | 1.73e-03 | 11 | 169 | 2 | EFO_0004810, GO_0050896 | |
| Disease | Liver Cirrhosis, Experimental | A2M COL12A1 ASPN LCP1 BCR BGN JAK2 NCOR2 FAT1 SEMA6D HPGDS AGFG1 | 1.75e-03 | 774 | 169 | 12 | C0023893 |
| Disease | Schizophrenia | IMPA2 MPZL1 DCC CMYA5 LMOD2 SLC6A11 HPGDS KAT8 H1-4 H1-5 KMT2A PICK1 GNPAT | 1.79e-03 | 883 | 169 | 13 | C0036341 |
| Disease | sexual dimorphism measurement | FOXM1 ATXN2L MARCHF2 CDC20B NSD1 LCP1 CEP164 MADD NCOR2 CEP120 SLC12A3 CASKIN1 H1-4 ALPK3 MGA | 1.81e-03 | 1106 | 169 | 15 | EFO_0021796 |
| Disease | Neurodevelopmental Disorders | 2.04e-03 | 93 | 169 | 4 | C1535926 | |
| Disease | Myeloproliferative disease | 2.07e-03 | 12 | 169 | 2 | C0027022 | |
| Disease | IGF-1 measurement | 2.09e-03 | 488 | 169 | 9 | EFO_0004627 | |
| Disease | PR interval | 2.30e-03 | 495 | 169 | 9 | EFO_0004462 | |
| Disease | leukemia (is_implicated_in) | 2.44e-03 | 13 | 169 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | body weight | MTIF3 ATXN2L COPB1 ATP13A5 PARD3B DCC SH3PXD2B CEP120 MAST4 SEMA6D GSE1 IL1RAPL2 SKAP1 MLLT3 MGA UNC79 | 2.50e-03 | 1261 | 169 | 16 | EFO_0004338 |
| Disease | Adenoid Cystic Carcinoma | 2.66e-03 | 100 | 169 | 4 | C0010606 | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 2.80e-03 | 49 | 169 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.80e-03 | 49 | 169 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | basophil percentage of leukocytes | 2.85e-03 | 243 | 169 | 6 | EFO_0007992 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 2.97e-03 | 50 | 169 | 3 | C0023453 | |
| Disease | mannan-binding lectin serine protease 1 measurement | 3.26e-03 | 15 | 169 | 2 | EFO_0008223 | |
| Disease | QRS-T angle | 3.28e-03 | 106 | 169 | 4 | EFO_0020097 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 3.32e-03 | 52 | 169 | 3 | C0023452 | |
| Disease | electrocardiography | 3.61e-03 | 530 | 169 | 9 | EFO_0004327 | |
| Disease | Malignant neoplasm of breast | FOXM1 ATP7B ANK2 WDR88 PCDHB15 CD109 NUP214 BGN PIK3R4 IL1RAPL2 ABCB8 FGD5 CLSPN VPS13B | 3.64e-03 | 1074 | 169 | 14 | C0006142 |
| Disease | apolipoprotein A 1 measurement | LILRB2 RNF8 NSD1 SPG11 LCP1 CEP164 MADD NCOR2 SLC12A3 KMT2A MGA VPS53 | 3.67e-03 | 848 | 169 | 12 | EFO_0004614 |
| Disease | interleukin-1 beta measurement | 3.70e-03 | 54 | 169 | 3 | EFO_0004812 | |
| Disease | leukemia | 3.89e-03 | 55 | 169 | 3 | C0023418 | |
| Disease | tonsillectomy risk measurement | 3.96e-03 | 260 | 169 | 6 | EFO_0007924 | |
| Disease | Amyotrophic lateral sclerosis | 4.19e-03 | 17 | 169 | 2 | cv:C0002736 | |
| Disease | Acute myeloid leukemia | 4.19e-03 | 17 | 169 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 4.19e-03 | 17 | 169 | 2 | 601626 | |
| Disease | diffuse plaque measurement | ANK2 CD109 ZMAT4 ARFGEF3 NCOR2 SH3PXD2B MAST4 SHANK2 SEMA6D GSE1 ABCB8 | 4.44e-03 | 758 | 169 | 11 | EFO_0010699 |
| Disease | creatine kinase measurement | 4.74e-03 | 59 | 169 | 3 | EFO_0004534 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 4.74e-03 | 59 | 169 | 3 | EFO_0022248 | |
| Disease | triglycerides to total lipids in large HDL percentage | 4.97e-03 | 60 | 169 | 3 | EFO_0022330 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 5.23e-03 | 19 | 169 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | urolithiasis | 5.70e-03 | 63 | 169 | 3 | MONDO_0024647 | |
| Disease | atrial fibrillation | 5.70e-03 | 371 | 169 | 7 | EFO_0000275 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITTESLKSLIPDIKP | 866 | Q9UKV3 | |
| SPLPGDVKVLSEKAI | 301 | Q9H6S1 | |
| PLELKTFLKVGNTSP | 496 | Q9NWW7 | |
| PQIKDSKGDSVLTLP | 2231 | A6H8Y1 | |
| IDIPRISSSLGKKPS | 641 | Q9NR48 | |
| GPKASKSPVEAIITL | 581 | Q4VNC0 | |
| PATLSILGESKKVLP | 1531 | Q96Q42 | |
| VFGPTLLRPSEKESK | 1206 | P11274 | |
| PLKPLSAAEKIASIG | 766 | Q6ULP2 | |
| KSKVAPLSLGPIDIE | 211 | P35670 | |
| APDSTTPGKKLIDRI | 116 | Q9Y6D6 | |
| KEPKPDSNLLTITSG | 261 | P42568 | |
| TSSLPQKDLKIPGLE | 236 | Q96G28 | |
| GKPSEQLTPTRAEKL | 426 | Q14687 | |
| KAVPGEVDTLRKLSP | 406 | Q96L96 | |
| PLSDILKGRTETLKP | 891 | Q5M775 | |
| LLTQKPLFPGKSEID | 631 | P21127 | |
| VSVKGLAPKRSEALP | 121 | Q9Y4F5 | |
| TPLVLATESKPELTG | 336 | Q9NVE4 | |
| LLSSSLPKLKELPVE | 951 | P78524 | |
| LTTKLIKPSSPVLGL | 166 | Q569K6 | |
| RIAEAKLTSVPKGLP | 226 | Q9BXN1 | |
| LAPTDVKELSTKEPG | 501 | Q8WWM7 | |
| KDTVIKPLLVEPEGL | 896 | P01023 | |
| QTTSGEKSLIKEPLP | 511 | Q8WWL7 | |
| KEESHPKTLGKLPTL | 336 | Q8TBY0 | |
| RSLGKAPASLPTEEK | 2601 | Q96L73 | |
| KLSDPGISITVLPKD | 696 | O60674 | |
| DSIPEVLTELGSLKP | 666 | Q9Y5G5 | |
| DLLELLVPGVSKKPS | 211 | Q8N149 | |
| STPKPLSKLLGSLDE | 536 | Q9H1A4 | |
| PLIEETPIGSIKDKV | 1756 | Q01484 | |
| KLNPDTGELKTSTPL | 3071 | Q14517 | |
| KGKIPPESTLIFNID | 116 | Q9NWM8 | |
| KGIPVKPTSAESGLL | 2846 | Q8WXI7 | |
| TKDRSLTGKLEPVSP | 136 | Q9Y618 | |
| KPIGGEIEVTPSALK | 116 | Q8TEW8 | |
| EGPPLAKVEASATLK | 1111 | Q8WXD9 | |
| SAPKDLTVITREGKP | 946 | P43146 | |
| QLKPEEIKSGTTAPL | 5206 | Q9NU22 | |
| PSIKEKLAGSPIRTS | 1261 | Q8WXG6 | |
| KEETLVIPSTGIKLP | 96 | Q96GA3 | |
| PLAAGLLKKVAEETP | 231 | Q9P0N8 | |
| PEVLSPTVKGKLLTG | 1191 | Q8IWI9 | |
| VGSPEKPLSDLGKLS | 346 | Q9H7Z6 | |
| DLKLDIPTGTTPQRK | 916 | P52732 | |
| EIKSTLPFGKIPILE | 41 | O60760 | |
| VTLKESGPVLVKPTE | 21 | A0A0B4J1V2 | |
| LPVGLRQKSLTEKTP | 46 | Q6P5Q4 | |
| GIPANKKLSTTLPEI | 236 | Q8N5G2 | |
| TISLLTGSEPPKAKD | 511 | Q00613 | |
| PKTGPTLRKELILSS | 151 | Q9H2K0 | |
| FKDPKISTSLPVLDL | 541 | P13796 | |
| GIPSEIISPKKVAEL | 151 | Q8NCN5 | |
| LKSVPKEISPDTTLL | 81 | P21810 | |
| SEAKLTGIPKDLPET | 216 | P21810 | |
| ATLGDLKLVEKPSPL | 761 | P53618 | |
| KPTLDPIITVEGLRK | 231 | Q9H8E8 | |
| KKPITKSSPSLLIES | 626 | Q6ZNL6 | |
| KVASETSPLPLKIDG | 736 | Q9H706 | |
| LPVSGTKPDLIERLK | 406 | Q9ULH7 | |
| LIKSGEISLPIKEEP | 906 | Q9ULH7 | |
| EISLPIKEEPSPISK | 911 | Q9ULH7 | |
| KLNKPPETLITTIDS | 91 | P00167 | |
| GTPSLRPKATVKLTE | 146 | Q9BYJ0 | |
| SDLLELLVPGVSKKP | 211 | Q8N423 | |
| KKEVILPTPEGSTIL | 451 | Q9H1U4 | |
| TSSKLETPPSKLGEL | 1306 | P35658 | |
| LPPASTSKKEELALL | 461 | Q3SXY7 | |
| KIPETSSLGTVFPLK | 141 | Q9Y5E8 | |
| PLSEGQPSLKKIILS | 96 | Q14641 | |
| PRKSPSDTEGLVKSL | 216 | O95297 | |
| SKALVLTEIGPKRDP | 166 | O14732 | |
| LTEIGPKRDPATLKL | 171 | O14732 | |
| DKGSPEKTLSALLLP | 536 | Q86VI3 | |
| IVFGPTLLKPEKETG | 806 | Q8IWW6 | |
| LSPALKAPEKTRETG | 286 | Q13415 | |
| SVADSLKAVLLKSPP | 271 | Q5EBM0 | |
| EKGSFKTLTLPSLPL | 81 | Q6YHK3 | |
| LLLENKPSVEKTTPT | 1111 | Q6WRI0 | |
| RKATGPPVSELITKA | 36 | P16401 | |
| ELLGVPKPKESTTGL | 296 | O15228 | |
| TLLGPKLSTSGIPEK | 96 | Q86V35 | |
| RAEALSEPLTKPVGK | 146 | Q9Y6W3 | |
| LKGTEKTLPVPVVSL | 1466 | Q99715 | |
| KPKGLELAPTLVITS | 321 | P28324 | |
| VLTPIKEKTLTGPKS | 366 | Q8N960 | |
| LKSPAIPEGKETLSK | 536 | Q5TH69 | |
| KPESIILPVEESKGS | 2406 | Q8N3K9 | |
| IAGSLAPPLTKEETV | 651 | Q8N1P7 | |
| TAKEASTPEPLGTKL | 916 | Q8N1P7 | |
| LKEVLKLPTAVFEGP | 171 | O60941 | |
| KPPRTLITEDGKALN | 286 | Q86X45 | |
| KLGKDSFPTQDLTPL | 361 | Q8TF76 | |
| PIKVTLPTIKDGSEA | 561 | Q9P0L2 | |
| SLQPPGIESEKSEKL | 2091 | O15021 | |
| VLKTPPEKETLTLGS | 106 | Q86Y33 | |
| ETLLLSPPVKVKGED | 471 | Q8NEP3 | |
| AKRTEVTLETLGPKP | 131 | Q08050 | |
| AKRKASGPPVSELIT | 31 | P10412 | |
| KTNLDLGPTAPSLEK | 971 | Q03164 | |
| KTESPSLGKVVPLSL | 701 | Q7Z2K8 | |
| PGDPLVISDIKKGSV | 596 | Q9Y3R0 | |
| EKEGLILPETLPLTK | 131 | O43889 | |
| VLLLPETKGKALPET | 511 | O15244 | |
| PSPVLRLVLSGEKKE | 231 | O43432 | |
| ESLIGLKNPEKSFPV | 341 | P48444 | |
| VQGKSLKEFSDILPP | 391 | Q6UY18 | |
| PKTSLIPLKPLTETE | 56 | Q8N323 | |
| TTSPVLGLKIKEGPV | 236 | Q01101 | |
| KDFTLTLPPGKIVAL | 491 | Q9NUT2 | |
| ITASVKDLPGLKTPV | 146 | Q7L099 | |
| VLGSPKELLKLSVPS | 81 | P78382 | |
| KTPGLPKDVSVAELL | 241 | P05423 | |
| DIDAIPLVLPASKGK | 16 | Q96KN7 | |
| KLTALEPSKTTGAPI | 206 | O76064 | |
| VTLEKSPALAPGKLS | 831 | O14513 | |
| KTPLISLKPLTETEL | 56 | Q6UWF7 | |
| QKLEASLKLPPVGST | 641 | Q58EX7 | |
| KEEPSGSNLPKILSI | 61 | Q9P212 | |
| TTELKVTALLTDKPP | 226 | Q9NP60 | |
| LGSEVKVKPPVLESG | 196 | O15353 | |
| ISSKSAGLPVPKLRE | 1241 | Q8IVL1 | |
| KLPVALDPGAKISVI | 116 | P04843 | |
| LKPSPKLASLIDGSS | 276 | Q9NSE4 | |
| LPDSPGDKLVIVKFV | 1151 | Q68CZ2 | |
| GSLVEKLPDSPALAK | 566 | Q13586 | |
| PAGVSRAKITPLTLK | 156 | Q96A09 | |
| GDVTEIKSPILSGPK | 1606 | Q9UPX8 | |
| LLEVLSGERLPKPTK | 91 | Q01082 | |
| LPSVEVDVKAPGAKL | 2281 | Q8IVF2 | |
| TDVFPLLGSVLKDPK | 41 | Q6ZSU1 | |
| TSSTPEVKPLKSLLG | 151 | P52594 | |
| EVKPLKSLLGDSAPT | 156 | P52594 | |
| SKQSKGLEERLSPPL | 461 | Q9UPV0 | |
| TDSKGIIEPPEGTKI | 311 | Q9Y471 | |
| DVVPVTLAPKKLDGA | 571 | Q9HAW4 | |
| KTLITIGGLPDPKTL | 841 | Q14028 | |
| KEEKSVLILPPRAGT | 1091 | Q14028 | |
| VQLLGIEASKLPKSP | 1066 | Q99570 | |
| STPTEKPKLLALGEN | 96 | Q96JI7 | |
| SKPDVITLLEQGKEP | 51 | Q9Y2G7 | |
| DQDPLSKIPFKILSG | 86 | Q6ZMY6 | |
| IKELGTLIPKSSDPE | 366 | P19532 | |
| PLKLPSLNKDGSVSE | 2336 | Q15413 | |
| SLPPRKESIIKSEGE | 521 | A1X283 | |
| KPRGLTKADIEQLPS | 351 | Q7L0R7 | |
| PEKLLPNRKGSTESS | 126 | Q658T7 | |
| SKISALEGLLKPQTP | 211 | O60667 | |
| KPTLRTPVKLESIDG | 746 | Q8TEQ6 | |
| SKPDLITLLEQGKEP | 51 | Q96SK3 | |
| KSVIIPKLDDSSKLP | 1076 | O15014 | |
| KVTLELKPLSTLQPG | 316 | Q8N0Z6 | |
| PEKLLSVFKGAPVEL | 26 | A0A0A6YYK6 | |
| LVGTLIPPSEDKASK | 301 | P55017 | |
| TEGTLPEKLQKLTTP | 576 | P48066 | |
| TSPKKAAEPTVDLLG | 206 | Q8IYB5 | |
| KGPKTSLSLRAPETV | 1026 | P08922 | |
| TLTDGTLKKLESPPP | 366 | Q5VIR6 | |
| TKVGSQRDLPSKLDP | 586 | O15090 | |
| ILPPLDKEKGETLLS | 1681 | Q07157 | |
| LSIGVKSKNPLPTLE | 836 | Q7Z7G8 | |
| GPSISKPDVITLLDE | 46 | Q9HCL3 | |
| VSLGLPFTKPKVISL | 51 | O60765 | |
| SVPGSKKVILDLPLV | 281 | Q9H3M7 | |
| LLTSRKELPPNGDTK | 741 | Q8NFY4 | |
| LKSTPGGLSDTIPLK | 71 | Q5T292 | |
| EDKLGIPTVPGKVTL | 11 | Q9NRD5 | |
| TGLELETPSLVPVKK | 211 | Q96QC0 | |
| LPPKVSEGKDVLLLV | 41 | Q15238 | |
| LLGEKTPLKTTATPL | 106 | Q9H898 | |
| ILPGSVGIKEPTEEK | 251 | Q86WV1 | |
| LLTKGFINEKDPTLP | 1126 | A6NCI4 | |
| LLGDAPVSPSSQKLK | 196 | Q9NYB0 | |
| VKGPVESKRALSLPE | 1231 | Q9P2D8 | |
| SEAKVQLKGIDPPTL | 71 | Q2WGJ6 | |
| LKELTLSANPGITPK | 146 | Q5JTD7 | |
| EIPLSPEATLAKKSL | 581 | E9PAV3 | |
| DLTEPVPTLDLGKKL | 16 | Q8TDC0 | |
| VPTLDLGKKLSVPQD | 21 | Q8TDC0 | |
| PEKIPSTGKLVLTLT | 476 | P16519 | |
| KLPFPLSTLATIKDD | 386 | Q9NQS3 |